Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EBIT Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -8.272.0011.90-5.320.04

What is the latest EBIT Growth ratio of MEDICAMEN BIOTECH ?

The latest EBIT Growth ratio of MEDICAMEN BIOTECH is -8.27 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-8.27
Mar20232.00
Mar202211.90
Mar2021-5.32
Mar20200.04

How is EBIT Growth of MEDICAMEN BIOTECH Trending?

Years EBIT Growth % Change
Mar2024 -8.27
Negative
Mar2023 2
-83.19
Mar2022 11.9
Positive
Mar2021 -5.32
Negative
Mar2020 0.04 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EBIT Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹481.8 Cr -2.9% -12.7% -10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.9%

-12.7%

-10.6%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses